Japan's RegCell raises $45.8M for Treg cell therapies, will move to US
Cell therapy biotech RegCell is hoping to bridge science from Japan with the US biotech industry to develop new cell therapies for autoimmune conditions. It announced Tuesday that it raised $45.8 million — $8.5 million in ...
